{"schema_version":"1","generated_at":"2026-11-16T23:08:33.316Z","data_as_of":null,"url":"https://www.findmykol.com/kol/brian-heiss","json_url":"https://www.findmykol.com/kol/brian-heiss/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"brian-heiss","name":"Brian Heiss","credential":"MD, MA","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Chicago","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1922426352","orcid":"0000-0002-7858-841X","openalex":"A5035939498"},"summary":"Brian Heiss is an Oncology physician. OpenAlex indexes 28 publications with 588 citations (h-index 13).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":28,"cited_by_count":588,"h_index":13,"latest_activity_year":2025,"source":"works"},"prescribing":{"data_year":2021,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":54.2,"classes_total":2,"classes":[{"class":"Cytochrome P450 17A1 Inhibitor","setting":"prescribed","share_pct":38.5,"drugs":[{"name":"Abiraterone Acetate","share_pct":100}],"max_beneficiaries":null},{"class":"Androgen Receptor Inhibitor","setting":"prescribed","share_pct":15.6,"drugs":[{"name":"Xtandi","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":29.2,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":29.2,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":16.7,"classes_total":1,"classes":[{"class":"Statin","setting":"prescribed","share_pct":16.7,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2021,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":28,"shown":5,"withheld":23,"matched_by":"OpenAlex author record","recent":[{"title":"FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ","year":2025,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-25-1231","status":"verified"},{"title":"The comeback of orchiectomy in advanced prostate cancer- is that feasible?","year":2025,"journal":"Urologic Oncology Seminars and Original Investigations","source_url":"https://doi.org/10.1016/j.urolonc.2025.08.025","status":"verified"},{"title":"Feasibility of surgical orchiectomy in prostate cancer patients on long term luteinizing hormone-releasing hormone (LHRH) agonist therapy.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.5_suppl.265","status":"verified"},{"title":"Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.02105","status":"verified"},{"title":"FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma","year":2024,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-24-1199","status":"verified"}],"source":"works"},"contact":{"address_1":"5841 S MARYLAND AVE # MC2115","city":"Chicago","state":"IL","zip":"606371443","phone":"773-702-2614","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1922426352","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":23}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-09-06","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2021}},"methodology_url":"https://www.findmykol.com/about#methodology"}